Global Epigenetics Drugs and Diagnostic Technologies Market Size, Status and Forecast 2022

August 2017 | 100 pages | ID: G673A004DDAEN
QYResearch

Abstracts

This report studies the global Epigenetics Drugs and Diagnostic Technologies market, analyzes and researches the Epigenetics Drugs and Diagnostic Technologies development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

• Celenge
• Eisai Pharmaceuticals
• Pharmacyclics
• Merck
• 4SC AG
• Acetylon Pharmaceuticals, Inc.
• Astex Pharmaceuticals Inc.
• CellCentric Ltd.
• Celleron Therapeutics Ltd.
• Chroma Therapeutics Ltd.
• Epigentek Group Inc.
• EnVivo Pharmaceuticals Inc.
• Epizyme, Inc. Illumina Inc.
• Merck & Company Inc.
• MDxHealth
• Oncolys BioPharma Inc.

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Epigenetics Drugs and Diagnostic Technologies can be split into

• DNA Methylation
• Chromatin Immunoprecipitation (ChIP) Technology

Market segment by Application, Epigenetics Drugs and Diagnostic Technologies can be split into

• Pharmaceutical and Biotechnology
• Academics
• Research Institutes
• Analytical Laboratories

Contents

Global Epigenetics Drugs and Diagnostic Technologies Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES

1.1 Epigenetics Drugs and Diagnostic Technologies Market Overview
  1.1.1 Epigenetics Drugs and Diagnostic Technologies Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Epigenetics Drugs and Diagnostic Technologies Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Epigenetics Drugs and Diagnostic Technologies Market by Type
  1.3.1 DNA Methylation
  1.3.2 Chromatin Immunoprecipitation (ChIP) Technology
1.4 Epigenetics Drugs and Diagnostic Technologies Market by End Users/Application
  1.4.1 Pharmaceutical and Biotechnology
  1.4.2 Academics
  1.4.3 Research Institutes
  1.4.4 Analytical Laboratories

2 GLOBAL EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES COMPETITION ANALYSIS BY PLAYERS

2.1 Epigenetics Drugs and Diagnostic Technologies Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Celenge
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Eisai Pharmaceuticals
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Pharmacyclics
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Merck
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 4SC AG
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Acetylon Pharmaceuticals, Inc.
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Astex Pharmaceuticals Inc.
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 CellCentric Ltd.
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Celleron Therapeutics Ltd.
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Chroma Therapeutics Ltd.
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Epigenetics Drugs and Diagnostic Technologies Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Epigentek Group Inc.
3.12 EnVivo Pharmaceuticals Inc.
3.13 Epizyme, Inc. Illumina Inc.
3.14 Merck & Company Inc.
3.15 MDxHealth
3.16 Oncolys BioPharma Inc.

4 GLOBAL EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2012-2017)
4.2 Global Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2012-2017)
4.3 Potential Application of Epigenetics Drugs and Diagnostic Technologies in Future
4.4 Top Consumer/End Users of Epigenetics Drugs and Diagnostic Technologies

5 UNITED STATES EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Epigenetics Drugs and Diagnostic Technologies Market Size (2012-2017)
5.2 United States Epigenetics Drugs and Diagnostic Technologies Market Size and Market Share by Players (2016 and 2017)

6 EU EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Epigenetics Drugs and Diagnostic Technologies Market Size (2012-2017)
6.2 EU Epigenetics Drugs and Diagnostic Technologies Market Size and Market Share by Players (2016 and 2017)

7 JAPAN EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Epigenetics Drugs and Diagnostic Technologies Market Size (2012-2017)
7.2 Japan Epigenetics Drugs and Diagnostic Technologies Market Size and Market Share by Players (2016 and 2017)

8 CHINA EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES DEVELOPMENT STATUS AND OUTLOOK

8.1 China Epigenetics Drugs and Diagnostic Technologies Market Size (2012-2017)
8.2 China Epigenetics Drugs and Diagnostic Technologies Market Size and Market Share by Players (2016 and 2017)

9 INDIA EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES DEVELOPMENT STATUS AND OUTLOOK

9.1 India Epigenetics Drugs and Diagnostic Technologies Market Size (2012-2017)
9.2 India Epigenetics Drugs and Diagnostic Technologies Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size (2012-2017)
10.2 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Epigenetics Drugs and Diagnostic Technologies Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Epigenetics Drugs and Diagnostic Technologies Revenue and Growth Rate (2017-2022)
  11.1.2 EU Epigenetics Drugs and Diagnostic Technologies Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Epigenetics Drugs and Diagnostic Technologies Revenue and Growth Rate (2017-2022)
  11.1.4 China Epigenetics Drugs and Diagnostic Technologies Revenue and Growth Rate (2017-2022)
  11.1.5 India Epigenetics Drugs and Diagnostic Technologies Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Epigenetics Drugs and Diagnostic Technologies Revenue and Growth Rate (2017-2022)
11.2 Global Epigenetics Drugs and Diagnostic Technologies Market Size (Value) by Type (2017-2022)
11.3 Global Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2017-2022)

12 EPIGENETICS DRUGS AND DIAGNOSTIC TECHNOLOGIES MARKET DYNAMICS

12.1 Epigenetics Drugs and Diagnostic Technologies Market Opportunities
12.2 Epigenetics Drugs and Diagnostic Technologies Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Epigenetics Drugs and Diagnostic Technologies Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Epigenetics Drugs and Diagnostic Technologies Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Epigenetics Drugs and Diagnostic Technologies Product Scope
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) (2012-2017)
Table Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Share by Regions in 2016
Figure United States Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Share by Type in 2016
Figure DNA Methylation Market Size (Million USD) and Growth Rate (2012-2017)
Figure Chromatin Immunoprecipitation (ChIP) Technology Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Share by Application in 2016
Figure Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate in Pharmaceutical and Biotechnology (2012-2017)
Figure Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate in Academics (2012-2017)
Figure Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate in Research Institutes (2012-2017)
Figure Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate in Analytical Laboratories (2012-2017)
Table Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Players (2016 and 2017)
Figure Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2016
Figure Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2017
Table Celenge Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Celenge (2012-2017)
Figure Celenge Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Eisai Pharmaceuticals Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Eisai Pharmaceuticals (2012-2017)
Figure Eisai Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Pharmacyclics Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Pharmacyclics (2012-2017)
Figure Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table 4SC AG Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of 4SC AG (2012-2017)
Figure 4SC AG Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Acetylon Pharmaceuticals, Inc. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Acetylon Pharmaceuticals, Inc. (2012-2017)
Figure Acetylon Pharmaceuticals, Inc. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Astex Pharmaceuticals Inc. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Astex Pharmaceuticals Inc. (2012-2017)
Figure Astex Pharmaceuticals Inc. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table CellCentric Ltd. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of CellCentric Ltd. (2012-2017)
Figure CellCentric Ltd. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Celleron Therapeutics Ltd. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Celleron Therapeutics Ltd. (2012-2017)
Figure Celleron Therapeutics Ltd. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Chroma Therapeutics Ltd. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Chroma Therapeutics Ltd. (2012-2017)
Figure Chroma Therapeutics Ltd. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Epigentek Group Inc. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Epigentek Group Inc. (2012-2017)
Figure Epigentek Group Inc. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table EnVivo Pharmaceuticals Inc. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of EnVivo Pharmaceuticals Inc. (2012-2017)
Figure EnVivo Pharmaceuticals Inc. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Epizyme, Inc. Illumina Inc. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Epizyme, Inc. Illumina Inc. (2012-2017)
Figure Epizyme, Inc. Illumina Inc. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Merck & Company Inc. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Merck & Company Inc. (2012-2017)
Figure Merck & Company Inc. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table MDxHealth Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of MDxHealth (2012-2017)
Figure MDxHealth Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Oncolys BioPharma Inc. Basic Information List
Table Epigenetics Drugs and Diagnostic Technologies Business Revenue (Million USD) of Oncolys BioPharma Inc. (2012-2017)
Figure Oncolys BioPharma Inc. Epigenetics Drugs and Diagnostic Technologies Business Revenue Market Share in 2016
Table Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Type (2012-2017)
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Type in 2012
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Type in 2013
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Type in 2014
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Type in 2015
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Type in 2016
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Type in 2017
Table Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application (2012-2017)
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application in 2012
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application in 2013
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application in 2014
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application in 2015
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application in 2016
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Epigenetics Drugs and Diagnostic Technologies
Figure United States Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Players (2012-2017)
Figure United States Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2016
Figure United States Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2017
Figure EU Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Players (2012-2017)
Figure EU Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2016
Figure EU Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2017
Figure Japan Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Players (2012-2017)
Figure Japan Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2016
Figure Japan Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2017
Figure China Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Players (2012-2017)
Figure China Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2016
Figure China Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2017
Figure India Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Players (2012-2017)
Figure India Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2016
Figure India Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2017
Figure Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2016
Figure Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size Share by Players in 2017
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Regions (2017-2022)
Table Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Regions (2017-2022)
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Regions in 2017
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Regions in 2022
Figure United States Epigenetics Drugs and Diagnostic Technologies Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Epigenetics Drugs and Diagnostic Technologies Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Epigenetics Drugs and Diagnostic Technologies Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Epigenetics Drugs and Diagnostic Technologies Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Epigenetics Drugs and Diagnostic Technologies Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Epigenetics Drugs and Diagnostic Technologies Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Type (2017-2022)
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Type in 2017
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Type in 2022
Table Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application (2017-2022)
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application in 2017
Figure Global Epigenetics Drugs and Diagnostic Technologies Market Size (Million USD) by Application in 2022